IMCC
IM Cannabis Corp.
Healthcare — Drug Manufacturers - Specialty & Generic
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
None
$2.17
$-0.08 (-3.56%)
Price History
52-Week Range
Sign in to add IMCC to a watchlist or set price alerts.
Fundamentals
| Market Cap | $1.40M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.12 |
| EPS (TTM) | $-2.21 |
| Dividend Yield | - |
| Profit Margin | -27.25% |
| Revenue Growth | -30.60% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 32.7 |
| Beta | 1.98 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $3.75 |
| 52-Week Low | $0.12 |
| 50-Day Avg | $0.25 |
| 200-Day Avg | $1.03 |
| Avg Volume | $4.21M |
| Volume | 149.9K |
Performance Analysis
NEUTRALIMCC presents a mixed picture with both positive and negative indicators.
~
Trading at 56% of its 52-week range.
~
RSI at 32.7 is in neutral territory.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
-
Revenue declined 30.6% year-over-year.
-
Operating at a loss with -27.2% margin.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:15 UTC
Back to Screener Export Report